(Q41687447)

7 October 2017

1 reference

title

Glycation, oxidation, and lipoxidation in the development of diabetic complications (English)

1 reference

ORCID Public Data File 2021

7 October 2017

1 reference

author name string

Kennedy AL

series ordinal

1

1 reference

PubMed ID

9439553

7 October 2017

Lyons TJ

series ordinal

2

1 reference

7 October 2017

1 December 1997

1 reference

7 October 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

7 October 2017

46

1 reference

7 October 2017

12 Suppl 1

1 reference

7 October 2017

14-21

1 reference

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Crosslines A and B as candidates for the fluorophores in age- and diabetes- related cross-linked proteins, and the diacetates produced by Maillard reaction of a-N-acetyl-L-lysine with D-glucose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Non-enzymatic glycosylation of skin collagen in patients with type 1 (insulin-dependent) diabetes mellitus and limited joint mobility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Formation of reactive intermediates from Amadori compounds under physiological conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Pathways of Formation of Glycoxidation Products during Glycation of Collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Non-enzymatic glycosylation of human serum lipoproteins. Elevated epsilon-lysine glycosylated low density lipoprotein in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Glycosylation of LDL decreases its ability to interact with high-affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Lipoprotein oxidation and lipoprotein-induced cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Immune mechanisms of atherosclerosis in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Modification of lipoproteins in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Interaction of very-low-density lipoprotein isolated from type I (insulin-dependent) diabetic subjects with human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Metabolism by human endothelial cells of very low density lipoprotein subfractions isolated from type 1 (insulin-dependent) diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

The role of lipoprotein(a) in the vascular complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Effect of glycation on the properties of lipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Glycated albumin modified by Amadori adducts modulates aortic endothelial cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Amadori glucose adducts modulate mesangial cell growth and collagen gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

7 January 2021

Glycosylated collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Increased glycosylation of glomerular basement membrane collagen in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Evidence for progressive, age-related structural changes in post-mature human collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Relation between complications of type I diabetes mellitus and collagen-linked fluorescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Advanced glycosylation end products in patients with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

The effect of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Probucol inhibits oxidative modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

The antioxidant butylated hydroxytoluene protects against atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990311-5

10.1016/S0026-0495(97)90311-5

7 January 2021

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

9439553